Initial analysis revealed that IGF2BP3 expression in gastrointestinal cancers exceeded the median expression levels observed across a broad range of cancers, laying the groundwork for further investigation into its diagnostic and prognostic significance in gastrointestinal cancers. Here, IGF2BP3 is linked to cancer.